- Business Wire•5 days ago
TransEnterix, Inc. announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the Cowen and Company 37th Annual Health Care Conference at the Boston Marriott Copley Place in Boston.
- Business Wire•6 days agoTransEnterix Schedules Fourth Quarter and Fiscal Year 2016 Financial and Operating Results Conference Call for March 6, 2017
TransEnterix, Inc. announced today that it plans to release fourth quarter and fiscal year 2016 financial and operating results after the market closes on Monday, March 6, 2017.
- Business Wire•14 days ago
TransEnterix, Inc. , a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that the Company has successfully begun clinical use of the Senhance Robotic Surgical System in France as part of its Clinical Leadership Program.
TRXC : Summary for TransEnterix, Inc. - Yahoo Finance
TransEnterix, Inc. (TRXC)
NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
|Day's Range||1.30 - 1.34|
|52 Week Range||1.03 - 6.10|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.19|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|